商品介绍
Product Description
KAC’s MC-210 Mycoplasma Removal Agent (MRA) contains quinoline as an antibiotic due to its mycoplasmacidal properties. Quinoline inhibits mycoplasma DNA gyrase or the topoisomerase IV enzyme and interferes with DNA replication. Recommended treatment dose is 0.5 μg/mL for 1 week. Developed by Dainippon Pharmaceuticals, it has proven to be an effective elimination treatment with low cell toxicity for over 20 years.
MC-210is a cost-effective solution for eliminating mycoplasma contamination. This agent demonstrates high removal effects against common contaminants such asmycoplasma orale.
Mycoplasma contamination can alter an endless number of parameters in unpredictable ways. Mycoplasma often cohabits with your cells instead of killing your cultures and it skews titers before producing noticeable effects. It can interfere withcell migration, signal transduction, lymphocyte activation, and cytokine expression.
Characteristics:
- Exerts potent antimycoplasma effects for a diverse range of mycoplasma.
- Demonstrated mycoplasmacidal activity. Accordingly, once mycoplasma is removed from cultured cells, mycoplasma does not grow again.
- Simple to use - To remove contamination, just add this agent and culture for about one week.
Size: 5mL
Concentration: 50 µg/mL
Storage method:
Stable at room temperature (4°C - 37°C). Please protect from light and store in the dark.
Instructions for Use:
1. Add the agent at a final concentration of 0.5µg/mL
to cultured cells contaminatedby mycoplasma
and wait for one week.
Example: With 10mL of culture media
in a 25cm² culture flask, add 0.1mL of agent.
2. When the culture media is changed,
add the agent at acomparable concentration.
3. After one week, add media without the agent
and verify that there is no mycoplasma
growth in the cell culture.
Precautions:
This agent is for research purposes and should be used only as a mycoplasmacidal agent for cell culture. Please strictly follow the required concentration for use (0.5µg/mL). If mycoplasma is still observed after treatment, increase the concentration to1µg/mL.
Toxicity of this agent to cultured cells is low, and cytotoxicity was not observed at the required concentration. However, for specific functions of cells, please verify that there are no abnormalities after mycoplasma removal.
Reference Data:
Documents:
Specifications (Coming Soon)
Material Safety Data Sheet(Coming Soon)
品牌介绍
"iwaichem公司成立于1947年，主要在日本东京生产和销售高纯试剂，超过60年的经营历史，zui近在生命科学领域销售有大的增长，特别是在诸如分子生物学，基因工程及免疫学。
我们和国内外450家生物技术公司有合作关系，并有70人的销售团队，2500多家研究机构和制药公司客户，iwaichem在日本有1.6亿美金的销售额。"
公司介绍
销售排行
问答列表
厂家直采
全球直采 正品优价
正品保障
厂家直发 有线跟踪
正规清关
CIF100%正规报关，提供发票
及时交付
限时必达 不达必赔
总部地址：
江苏省苏州市工业园区星湖街218号 苏州生物医药产业园一期（生物纳米园）A4-216(邮编：215125)
工作时间：周一至周五9:00~18:00
技术支持：
短信：18915418616
服务热线：
4000-520-616（全国）
☏ 0512-67156496（苏州）
版权信息：
© 2015- 苏州蚂蚁淘生物科技有限公司 版权所有 中国
友情链接：
联系QQ:764052152
免责声明：
本站有部分内容来自互联网，如无意中侵犯了某个媒体 、公司 、企业或个人等的知识产权，请来电或致函告之，
本网站将在规定时间内给予删除等相关处理。
本网站将在规定时间内给予删除等相关处理。
扫描二维码关注官方微信
获取最新促销及产品信息